Effects of Tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 dabetes
Pirro V, Roth KD, Lin Y, et al.
J Clin Endocrinol Metab. 2022;107(2):363-378.
Leggi
Pirro V, Roth KD, Lin Y, et al.
J Clin Endocrinol Metab. 2022;107(2):363-378.
Leggi
Valadan M, Bahramnezhad Z, Golshahi F, Feizabad E
BMC Pregnancy Childbirth. 2022;22(1):71.
Leggi
Seeberg KA, Borgeraas H, Hofsø D, et al.
Ann Intern Med. 2022;175(1):74-83
Leggi
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Berg DD, Docherty KF, Sattar N, et al.
Circulation. 2022;145(3):158-169
Leggi
Barrett CE, Koyama AK, Alvarez P, et al.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65.
Leggi
25 gennaio 2022
Leggi
Lyu B, Grams ME, Chang A, et al.
Am J Cardiol. 2022;165:124-130.
Leggi
Ekhlaspour L, Town MA, Raghinaru D, et al.
Diabetes Technol Ther. Pub. online 12 January 2022
Leggi
Uemura F, Okada Y, Mita T, et al.
Diabetes Technol Ther. Pub. online 20 January 2022.
Leggi